PCL (A241820) Stock Overview
Provides multiplex in vitro diagnostic (IVD) products and platform services. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
A241820 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
PCL, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩302.00 |
| 52 Week High | ₩2,190.00 |
| 52 Week Low | ₩295.00 |
| Beta | 1.58 |
| 1 Month Change | 0% |
| 3 Month Change | -1.63% |
| 1 Year Change | -69.86% |
| 3 Year Change | -94.19% |
| 5 Year Change | -93.66% |
| Change since IPO | -90.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| A241820 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0% | 15.2% | 1.7% |
| 1Y | -69.9% | -14.7% | 87.0% |
Return vs Industry: A241820 underperformed the KR Medical Equipment industry which returned -9.3% over the past year.
Return vs Market: A241820 underperformed the KR Market which returned 3% over the past year.
Price Volatility
| A241820 volatility | |
|---|---|
| A241820 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 9.5% |
| Market Average Movement | 9.9% |
| 10% most volatile stocks in KR Market | 17.8% |
| 10% least volatile stocks in KR Market | 5.1% |
Stable Share Price: A241820's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: Insufficient data to determine A241820's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 31 | Soyeon Kim | www.pclchip.com |
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers HiSU solution, an automated multi-immune diagnostic system that performs various diagnostics, high-speed tests including blood screening, multiple cancer screening, autoimmune testing, etc. It also provides antigen and antibody diagnostic kits, including PCLOK II anti-HIV/HCV/syphilis, and PCLOK II HBsAg/HIV p24. In addition, the company offers platform services, such as SG ID for identifying novel target substances.
PCL, Inc. Fundamentals Summary
| A241820 fundamental statistics | |
|---|---|
| Market cap | ₩17.87b |
| Earnings (TTM) | -₩47.69b |
| Revenue (TTM) | ₩2.83b |
Is A241820 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A241820 income statement (TTM) | |
|---|---|
| Revenue | ₩2.83b |
| Cost of Revenue | ₩11.12b |
| Gross Profit | -₩8.29b |
| Other Expenses | ₩39.40b |
| Earnings | -₩47.69b |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -805.94 |
| Gross Margin | -293.15% |
| Net Profit Margin | -1,686.70% |
| Debt/Equity Ratio | 93.8% |
How did A241820 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/18 06:32 |
| End of Day Share Price | 2025/03/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PCL, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.